IL99402A0 - 3-aryl-4(3h)quinazolinone cck antagonists and pharmaceutical formulations thereof - Google Patents

3-aryl-4(3h)quinazolinone cck antagonists and pharmaceutical formulations thereof

Info

Publication number
IL99402A0
IL99402A0 IL99402A IL9940291A IL99402A0 IL 99402 A0 IL99402 A0 IL 99402A0 IL 99402 A IL99402 A IL 99402A IL 9940291 A IL9940291 A IL 9940291A IL 99402 A0 IL99402 A0 IL 99402A0
Authority
IL
Israel
Prior art keywords
aryl
pharmaceutical formulations
cck antagonists
quinazolinone
quinazolinone cck
Prior art date
Application number
IL99402A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL99402A0 publication Critical patent/IL99402A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL99402A 1990-09-13 1991-09-04 3-aryl-4(3h)quinazolinone cck antagonists and pharmaceutical formulations thereof IL99402A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/581,943 US5075313A (en) 1990-09-13 1990-09-13 3-aryl-4(3H)quinazolinone CCK antagonists and pharmaceutical formulations thereof

Publications (1)

Publication Number Publication Date
IL99402A0 true IL99402A0 (en) 1992-08-18

Family

ID=24327210

Family Applications (1)

Application Number Title Priority Date Filing Date
IL99402A IL99402A0 (en) 1990-09-13 1991-09-04 3-aryl-4(3h)quinazolinone cck antagonists and pharmaceutical formulations thereof

Country Status (20)

Country Link
US (1) US5075313A (cs)
EP (1) EP0475755B1 (cs)
JP (1) JPH04247080A (cs)
KR (1) KR920006350A (cs)
CN (1) CN1059722A (cs)
AU (1) AU641043B2 (cs)
CA (1) CA2050994A1 (cs)
CZ (1) CZ279774B6 (cs)
DE (1) DE69113379T2 (cs)
ES (1) ES2078455T3 (cs)
FI (1) FI914262L (cs)
HU (1) HUT59128A (cs)
IE (1) IE913217A1 (cs)
IL (1) IL99402A0 (cs)
MX (1) MX9101035A (cs)
NO (1) NO913579L (cs)
NZ (1) NZ239712A (cs)
PT (1) PT98915A (cs)
YU (1) YU151691A (cs)
ZA (1) ZA917149B (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340801A (en) * 1991-05-08 1994-08-23 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having cholecystokinin and gastrin antagonistic properties
US5204354A (en) * 1992-02-14 1993-04-20 Merck & Co., Inc. Substituted quinazolinones as neurotensin antagonists useful in the treatment of CNS disorders
DK0573221T3 (da) * 1992-06-05 1998-10-07 Merck Sharp & Dohme Sulfatsaltet af en substitueret triazol, farmaceutiske præparater deraf og deres anvendelse i terapi
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
GB0031315D0 (en) * 2000-12-21 2001-02-07 Glaxo Group Ltd Indole derivatives
PT1355644E (pt) 2001-01-26 2006-11-30 Schering Corp Utilização de compostos azetidinona substituídos para o tratamento de sitosterolemia
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
ES2274013T3 (es) 2001-01-26 2007-05-16 Schering Corporation Combinaciones de activador(es) del receptor activado por el proliferador de los peroxisomas (ppar) e inhibidor(es)m de la absorcion de estelores y tratamientos para trastornos vasculares.
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
JP2005504091A (ja) 2001-09-21 2005-02-10 シェーリング　コーポレイション ステロール吸収阻害剤としてアゼチジノンを用いる黄色腫の処置
US7560449B2 (en) 2002-11-06 2009-07-14 Schering Corporation Methods and therapeutic combinations for the treatment of demyelination
ES2311806T3 (es) 2003-03-07 2009-02-16 Schering Corporation Compuesto de azetidinona sustituidos, fornulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
EP1606287B1 (en) 2003-03-07 2013-10-02 Merck Sharp & Dohme Corp. Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
WO2004081003A1 (en) 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholeterolemia
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US7348338B2 (en) * 2003-07-17 2008-03-25 Plexxikon, Inc. PPAR active compounds
WO2005009958A1 (en) * 2003-07-17 2005-02-03 Plexxikon, Inc. Ppar active compounds
GB0319126D0 (en) * 2003-08-14 2003-09-17 Smithkline Beecham Corp Chemical compounds
EP1819673A2 (en) * 2004-11-30 2007-08-22 Plexxikon, Inc. Indole derivatives for use as ppar active compounds
AU2005311826A1 (en) * 2004-11-30 2006-06-08 Plexxikon, Inc. Indole derivatives for use as PPAR active compounds
BRPI0615948A2 (pt) * 2005-09-07 2011-05-31 Plexxikon Inc composto ativo de ppar, sua composição, seu kit e seu uso
WO2007030574A2 (en) * 2005-09-07 2007-03-15 Plexxikon, Inc. 1 , 4 and 1 , 5-disubstituted indole derivatives for use as ppar active compounds
JP2009514954A (ja) * 2005-11-04 2009-04-09 ハイドラ バイオサイエンシズ インコーポレイテッド Ｔｒｐｖ３機能を変調するための化合物
PE20090159A1 (es) * 2007-03-08 2009-02-21 Plexxikon Inc COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs
WO2021154966A1 (en) 2020-01-29 2021-08-05 Kamari Pharma Ltd. Compounds and compositions for use in treating skin disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ192392A (en) * 1978-12-19 1983-02-15 M Ishikawa 3-(substituted (phenyl or pyridyl)) -3,4-dihydroquinazolin-4-ones
JPH03503650A (ja) * 1988-04-05 1991-08-15 アボツト・ラボラトリーズ Ｃｃｋアンタゴニストとしてのトリプトファン誘導体

Also Published As

Publication number Publication date
FI914262A7 (fi) 1992-03-14
DE69113379T2 (de) 1996-03-21
HUT59128A (en) 1992-04-28
CS279991A3 (en) 1992-04-15
US5075313A (en) 1991-12-24
NZ239712A (en) 1993-06-25
AU641043B2 (en) 1993-09-09
CA2050994A1 (en) 1992-03-14
FI914262A0 (fi) 1991-09-10
IE913217A1 (en) 1992-02-25
DE69113379D1 (de) 1995-11-02
KR920006350A (ko) 1992-04-27
ES2078455T3 (es) 1995-12-16
JPH04247080A (ja) 1992-09-03
HU912921D0 (en) 1992-01-28
CZ279774B6 (cs) 1995-06-14
FI914262L (fi) 1992-03-14
NO913579D0 (no) 1991-09-11
ZA917149B (en) 1992-05-27
EP0475755B1 (en) 1995-09-27
AU8382991A (en) 1992-03-19
NO913579L (no) 1992-03-16
PT98915A (pt) 1992-08-31
EP0475755A1 (en) 1992-03-18
YU151691A (sh) 1994-01-20
MX9101035A (es) 1992-05-04
CN1059722A (zh) 1992-03-25

Similar Documents

Publication Publication Date Title
ZA917149B (en) 3-aryl-4(3h)quinazolinone cck antagonists and pharmaceutical formulations thereof
IL103621A0 (en) Endothelin receptor antagonists and pharmaceutical compositions containing them
IL99246A0 (en) Angiotensin ii receptor antagonists and pharmaceutical compositions containing them
NZ314184A (en) Substituted quinazoline derivatives and pharmaceutical compositions
NZ233320A (en) 3-substituted-2-oxo-indole derivatives and pharmaceutical compositions
NZ236625A (en) Pyrimidine derivatives and pharmaceutical compositions
EP0498268A3 (en) 5-oxo-l-proline derivatives and pharmaceutical use thereof
NZ233875A (en) Substituted pyridazinone derivatives and pharmaceutical compositions
NZ221184A (en) Quinazoline derivatives and pharmaceutical compositions
NZ233790A (en) Benzocycloalkane derivatives and pharmaceutical compositions
IL112320A0 (en) Quinazoline-2,4- diones, their preparation and pharmaceutical compositions containing them
GB9217475D0 (en) Nauroprotective use cck antagonists
NZ233011A (en) Thieno-triazole-diazepine and pharmaceutical compositions
IL105551A0 (en) Quinazolines and pharmaceutical compositions containing them
NZ243627A (en) 3-deoxy-mannosamine derivatives and pharmaceutical compositions thereof; intermediate precursors
ZA915372B (en) Pyrazolidinone cck and gastrin antagonists and pharmaceutical formulations thereof
NZ237484A (en) Xanthine derivatives and pharmaceutical compositions
NZ233013A (en) Substituted thieno-triazolo-diazepine derivatives and pharmaceutical compositions
NZ239483A (en) Phosphonopyrrolidine or -piperidine derivatives and pharmaceutical compositions
NZ233121A (en) Substituted thiouracil derivatives and pharmaceutical compositions
ZA911065B (en) Chemical and pharmaceutical compositions
AP9000236A0 (en) Pharmaceutical formulations
NZ233940A (en) Cyclised n-oxo-tetrahydro-beta-carboline derivatives and pharmaceutical compositions thereof
NZ241331A (en) 3-phenyl-2-alkenamide derivatives and pharmaceutical compositions thereof
NZ231558A (en) Benzenesulphonamide derivatives and pharmaceutical compositions thereof